Enterprise Data Assets & Management in a Changing Landscape

The Information Value Chain in Global Life Sciences (BioPharma, Medical Devices, Authorities, eHealth) linked to globally applied Standards

As business models need to shift (or at least adapt), we will consider and together develop new processes with measurable (e.g. Patient) outcome by elaborating emerging technologies that can enable and deliver business value while reducing Total Cost of Ownership (TCO)
eHealth with Patients and Providers will need to be included in a transparent, measurable flow of information: ePatient Reported Outcome (ePRO) will be crucial to weight health economics in the digital world
The changing landscape calls for re-visiting current Business Models: In new markets, what are going to be information needs to be successful?
We will continuously improve our methods to help customer’s identify their new business opportunities and objectives, to include Social Media (Monitoring & Records Management for legal evidence), documenting interactions/transactions today